InflaRx (IFRX) Interest Coverage Ratio (QoQ) (2017 - 2026)
InflaRx (IFRX) Interest Coverage Ratio (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
InflaRx |
752.21 Mn |
752.21 Mn |
10,877.40 |
| Date | Value |
|---|
| Mar 31, 2026 |
-16.07% |
| Dec 31, 2025 |
-12.13% |
| Sep 30, 2025 |
-82.86% |
| Jun 30, 2025 |
20.97% |
| Mar 31, 2025 |
168.87% |
| Dec 31, 2024 |
-61.22% |
| Sep 30, 2024 |
73.12% |
| Jun 30, 2024 |
-34.60% |
| Mar 31, 2024 |
1,135.50% |
| Dec 31, 2023 |
-111.43% |
| Sep 30, 2023 |
16.72% |
| Jun 30, 2023 |
101,793,120,607,853.73% |
| Mar 31, 2023 |
-100.00% |
| Dec 31, 2022 |
104,386,991,407,088.97% |
| Sep 30, 2022 |
-100.00% |
| Jun 30, 2022 |
-77.37% |
| Mar 31, 2022 |
115,183,433.98% |
| Dec 31, 2021 |
-100.00% |
| Sep 30, 2021 |
-70.85% |
| Jun 30, 2021 |
113.12% |
